Use fundamental data analysis to confirm all available fundamental indicators of St Jude Medical to find out if markets are now mispricing the corporation. We found twenty-nine available financial indicators for St Jude which can be compared to its peers in the sector. To make sure the equity is not overpriced, please validate all St Jude Medical Inc fundamentals including its Shares Owned by Insiders, Cash per Share, Working Capital, as well as the relationship between Price to Sales and Earnings Per Share . Given that St Jude Medical has Number of Shares Shorted of 8.18 M, we advise you double-check St Jude latest market performance to make sure the company can sustain itself next year.Use St Jude to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of St Jude to be traded at $84.86 in 30 days
St Jude Medical Valuation Over Time
St Jude Company SummarySt Jude competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.
St Jude Price to Sales vs Working Capital
St Jude Medical Inc is rated second in price to sales category among related companies. It is currently regarded as top stock in working capital category among related companies reporting about 160,000,000 of Working Capital per Price to Sales.